Sage Journals: Discover world-class research

Retricted access

Research article

First published 2013-7

New Obesity Agents: Lorcaserin and Phentermine/Topiramate

Joshua W Fleming, Katie S McClendon, Daniel M Riche

Annals of Pharmacotherapy

Retricted access

Research article

First published 2012-11

Lorcaserin Hydrochloride

Dennis J. Cada, Terri L. Levien, Danial E. Baker

Hospital Pharmacy

Retricted access

Review article

First published 2017-11

Role of impulsivity and reward in the anti-obesity actions of 5-HT 2C receptor agonists

Guy A Higgins, Fiona D Zeeb, Paul J Fletcher

Journal of Psychopharmacology

Free access

Research article

First published 2014-6

Lorcaserin: A novel antiobesity drug

Dick B. S. Brashier, A. K. Sharma, Navdeep Dahiya [...]

Journal of Pharmacology and Pharmacotherapeutics

Retricted access

Letter

First published 2013-12

Response to “Lorcaserin and Phentermine/Topiramate

Joshua W. Fleming, Katie S. McClendon, Daniel M. Riche

Annals of Pharmacotherapy

Free access

Research article

First published 2014-1

New and Emerging Drug Molecules Against Obesity

Melvin George, Muthukumar Rajaram, Elangovan Shanmugam

Journal of Cardiovascular Pharmacology and Therapeutics

Retricted access

Letter

First published 2013-12

Lorcaserin and Phentermine/Topiramate: Two Leaps Forward in Weight Loss Pharmacotherapy

Lucas G. Hill

Annals of Pharmacotherapy

Free access

Research article

First published 2013-8

Safety of antiobesity drugs

Bernard Man Yung Cheung, Tommy Tsang Cheung, Nithushi Rajitha Samaranayake

Therapeutic Advances in Drug Safety

Free access

Review article

First published 2014-5

Pharmacotherapy for obesity: novel agents and paradigms

Sean Manning, Andrea Pucci, Nicholas Finer

Sage Open Chronic Disease

Retricted access

Review article

First published 2015-2

Pharmacological Management of Obesity in Pediatric Patients

Cassie L. Boland, John Brock Harris, Kira B. Harris

Annals of Pharmacotherapy

Search results